BHRB vs JAZZ · P/E 8.4, rev $445.0M vs P/E 1988, rev $2.28B
Burke & Herbert Financial Services Corp. Common Stock (BHRB) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Burke & Herbert Financial Services Corp. Common Stock (BHRB) is a banks - regional company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported BHRB revenue for 2025-12-31 was $445.0M. Net income was $117.3M. Revenue was up 21.5% from 2024-12-31 to 2025-12-31. BHRB currently screens at market cap $1.30B and trailing P/E 8.4.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
BHRB currently screens at market cap $1.30B and trailing P/E 8.4. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the BHRB and JAZZ stock pages for the full models.
Not investment advice.